Pang Phillip 4
4 · Vir Biotechnology, Inc. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Pang Phillip
Chief Medical Officer
Transactions
- Award
Common Stock
2023-02-22+60,000→ 201,198 total - Sale
Common Stock
2023-02-23$25.97/sh−2,878$74,750→ 198,320 total - Award
Stock Option (Right to Buy)
2023-02-22+70,000→ 70,000 totalExercise: $27.01Exp: 2033-02-21→ Common Stock (70,000 underlying)
Footnotes (3)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]25% of the shares subject to the stock option vest and become exercisable on February 22, 2024, and the remainder vest in 36 equal monthly installments thereafter.